Report cover image

Postbiotics Market Size, Share, Trends, Industry Analysis Report By Form (Powder, Capsules, Liquid, Tablets, and Others), By Type, By Distribution Channel, and By Region – Market Forecast, 2025–2034

Published Aug 01, 2025
Length 125 Pages
SKU # PLRS20381630

Description

The postbiotics market size is expected to reach USD 310.66 Million by 2034, according to a new study by Polaris Market Research. The report “Postbiotics Market Size, Share, Trends, Industry Analysis Report By Form (Powder, Capsules, Liquid, Tablets, and Others), By Type, By Distribution Channel, and By Region – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Postbiotics are emerging as functional ingredients in preventive healthcare and nutrition, offering scientifically validated benefits such as improved gut health, enhanced immune modulation, and metabolic support without the viability challenges associated with probiotics.

The market is growing significantly due to the rising consumer demand for safe, stable, and sustainable health solutions, increasing application in dietary supplements, functional foods, and pharmaceuticals, and continuous innovations that improve formulation flexibility and regulatory compliance.

Postbiotics Market Report Highlights

Based on form, the powder segment dominated the market in 2024, due to its stability, ease of formulation, and high compatibility with functional foods, beverages, and dietary supplements.

Based on type, short-chain fatty acids (SCFAs) held the largest share in 2024, owing to clinically validated role in maintaining gut health, regulating metabolism, and reducing inflammation.

In terms of distribution channel, online retail accounted for a significant share in 2024, fueled by the growing preference for e-commerce platforms offering a wide range of health products, subscription models, and home delivery convenience.

Asia Pacific accounted for a dominant share in 2024, supported by rising health and wellness awareness across China, India, and Southeast Asia.

North America is projected to grow at the fastest CAGR, attributed to strong consumer demand for functional foods and dietary supplements targeting digestive health and immune support.

Key players in the global market include Archer-Daniels-Midland Company, BASF SE, Beekeeper's Naturals, Inc., Bioflag Group, Cargill, Incorporated, DSM-Firmenich AG, Essential Formulas Incorporated, Glac Biotech Co., Ltd., Ildong Pharmaceutical Co., Ltd., Kerry Group plc, Kemin Industries, Inc., MCLS Europe B.V., Phileo by Lesaffre, Sabinsa Corporation, and POSTBIOTICA S.R.L.

Polaris Market Research has segmented the market report based on form, type, distribution channel, and region:

By Form Outlook (Revenue, USD Million, 2020–2034)

Powder

Capsules

Liquid

Tablets

Others

By Type Outlook (Revenue, USD Million, 2020–2034)

Short-chain fatty acids

Lipopolysaccharides

Muramly dipeptide

Indole

Teichoic acid

Lactose Pin

P40 molecule

By Distribution Channel Outlook (Revenue, USD Million, 2020–2034)

Online Retail

Supermarkets/Hypermarkets

Drug Stores

Retail Stores

Convenience Store

Others

By Regional Outlook (Revenue, USD Million, 2020–2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

125 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global Postbiotics Market Insights
4.1. Postbiotics Market – Market Snapshot
4.2. Postbiotics Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Increasing Prevalence of Lifestyle Disorders Driving Adoption of Postbiotics
4.2.1.2. Aging Population Increasing Demand for Immunity and Digestive Health Solutions
4.2.2. Restraints and Challenges
4.2.2.1. High R&D and Clinical Validation Costs
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Postbiotics Market Trends
4.6. Value Chain Analysis
5. Global Postbiotics Market, by Form
5.1. Key Findings
5.2. Introduction
5.2.1. Global Postbiotics Market, by Form, 2020-2034 (USD Million)
5.3. Powder
5.3.1. Global Postbiotics Market, by Powder, by Region, 2020-2034 (USD Million)
5.4. Capsules
5.4.1. Global Postbiotics Market, by Capsules, by Region, 2020-2034 (USD Million)
5.5. Liquid
5.5.1. Global Postbiotics Market, by Liquid, by Region, 2020-2034 (USD Million)
5.6. Tablets
5.6.1. Global Postbiotics Market, by Tablets, by Region, 2020-2034 (USD Million)
5.7. Others
5.7.1. Global Postbiotics Market, by Others, by Region, 2020-2034 (USD Million)
6. Global Postbiotics Market, by Type
6.1. Key Findings
6.2. Introduction
6.2.1. Global Postbiotics Market, by Type, 2020-2034 (USD Million)
6.3. Short-chain fatty acids
6.3.1. Global Postbiotics Market, by Short-chain fatty acids, by Region, 2020-2034 (USD Million)
6.4. Lipopolysaccharides
6.4.1. Global Postbiotics Market, by Lipopolysaccharides, by Region, 2020-2034 (USD Million)
6.5. Muramly dipeptide
6.5.1. Global Postbiotics Market, by Muramly dipeptide, by Region, 2020-2034 (USD Million)
6.6. Indole
6.6.1. Global Postbiotics Market, by Indole, by Region, 2020-2034 (USD Million)
6.7. Teichoic acid
6.7.1. Global Postbiotics Market, by Teichoic acid, by Region, 2020-2034 (USD Million)
6.8. Lactose Pin
6.8.1. Global Postbiotics Market, by Lactose Pin, by Region, 2020-2034 (USD Million)
6.9. P40 molecule
6.9.1. Global Postbiotics Market, by P40 molecule, by Region, 2020-2034 (USD Million)
7. Global Postbiotics Market, by Distribution Channel
7.1. Key Findings
7.2. Introduction
7.2.1. Global Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
7.3. Online Retail
7.3.1. Global Postbiotics Market, by Online Retail, by Region, 2020-2034 (USD Million)
7.4. Supermarkets/Hypermarkets
7.4.1. Global Postbiotics Market, by Supermarkets/Hypermarkets, by Region, 2020-2034 (USD Million)
7.5. Drug Stores
7.5.1. Global Postbiotics Market, by Drug Stores, by Region, 2020-2034 (USD Million)
7.6. Retail Stores
7.6.1. Global Postbiotics Market, by Retail Stores, by Region, 2020-2034 (USD Million)
7.7. Convenience Store
7.7.1. Global Postbiotics Market, by Convenience Store, by Region, 2020-2034 (USD Million)
7.8. Others
7.8.1. Global Postbiotics Market, by Others, by Region, 2020-2034 (USD Million)
8. Global Postbiotics Market, by Geography
8.1. Key Findings
8.2. Introduction
8.2.1. Postbiotics Market Assessment, By Geography, 2020-2034 (USD Million)
8.3. Postbiotics Market – North America
8.3.1. North America: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.3.2. North America: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.3.3. North America: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.3.4. Postbiotics Market – U.S.
8.3.4.1. U.S.: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.3.4.2. U.S.: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.3.4.3. U.S.: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.3.5. Postbiotics Market – Canada
8.3.5.1. Canada: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.3.5.2. Canada: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.3.5.3. Canada: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.4. Postbiotics Market – Europe
8.4.1. Europe: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.4.2. Europe: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.4.3. Europe: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.4.4. Postbiotics Market – UK
8.4.4.1. UK: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.4.4.2. UK: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.4.4.3. UK: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.4.5. Postbiotics Market – France
8.4.5.1. France: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.4.5.2. France: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.4.5.3. France: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.4.6. Postbiotics Market – Germany
8.4.6.1. Germany: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.4.6.2. Germany: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.4.6.3. Germany: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.4.7. Postbiotics Market – Italy
8.4.7.1. Italy: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.4.7.2. Italy: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.4.7.3. Italy: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.4.8. Postbiotics Market – Spain
8.4.8.1. Spain: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.4.8.2. Spain: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.4.8.3. Spain: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.4.9. Postbiotics Market – Netherlands
8.4.9.1. Netherlands: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.4.9.2. Netherlands: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.4.9.3. Netherlands: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.4.10. Postbiotics Market – Russia
8.4.10.1. Russia: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.4.10.2. Russia: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.4.10.3. Russia: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.4.11. Postbiotics Market – Rest of Europe
8.4.11.1. Rest of Europe: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.4.11.2. Rest of Europe: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.4.11.3. Rest of Europe: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.5. Postbiotics Market – Asia Pacific
8.5.1. Asia Pacific: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.5.2. Asia Pacific: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.5.3. Asia Pacific: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.5.4. Postbiotics Market – China
8.5.4.1. China: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.5.4.2. China: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.5.4.3. China: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.5.5. Postbiotics Market – India
8.5.5.1. India: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.5.5.2. India: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.5.5.3. India: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.5.6. Postbiotics Market – Malaysia
8.5.6.1. Malaysia: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.5.6.2. Malaysia: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.5.6.3. Malaysia: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.5.7. Postbiotics Market – Japan
8.5.7.1. Japan: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.5.7.2. Japan: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.5.7.3. Japan: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.5.8. Postbiotics Market – Indonesia
8.5.8.1. Indonesia: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.5.8.2. Indonesia: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.5.8.3. Indonesia: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.5.9. Postbiotics Market – South Korea
8.5.9.1. South Korea: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.5.9.2. South Korea: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.5.9.3. South Korea: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.5.10. Postbiotics Market – Australia
8.5.10.1. Australia: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.5.10.2. Australia: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.5.10.3. Australia: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.5.11. Postbiotics Market – Rest of Asia Pacific
8.5.11.1. Rest of Asia Pacific: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.5.11.2. Rest of Asia Pacific: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.5.11.3. Rest of Asia Pacific: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.6. Postbiotics Market – Middle East & Africa
8.6.1. Middle East & Africa: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.6.2. Middle East & Africa: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.6.3. Middle East & Africa: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.6.4. Postbiotics Market – Saudi Arabia
8.6.4.1. Saudi Arabia: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.6.4.2. Saudi Arabia: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.6.4.3. Saudi Arabia: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.6.5. Postbiotics Market – UAE
8.6.5.1. UAE: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.6.5.2. UAE: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.6.5.3. UAE: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.6.6. Postbiotics Market – Israel
8.6.6.1. Israel: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.6.6.2. Israel: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.6.6.3. Israel: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.6.7. Postbiotics Market – South Africa
8.6.7.1. South Africa: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.6.7.2. South Africa: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.6.7.3. South Africa: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.6.8. Postbiotics Market – Rest of Middle East & Africa
8.6.8.1. Rest of Middle East & Africa: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.6.8.2. Rest of Middle East & Africa: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.6.8.3. Rest of Middle East & Africa: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.7. Postbiotics Market – Latin America
8.7.1. Latin America: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.7.2. Latin America: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.7.3. Latin America: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.7.4. Postbiotics Market – Mexico
8.7.4.1. Mexico: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.7.4.2. Mexico: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.7.4.3. Mexico: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.7.5. Postbiotics Market – Brazil
8.7.5.1. Brazil: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.7.5.2. Brazil: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.7.5.3. Brazil: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.7.6. Postbiotics Market – Argentina
8.7.6.1. Argentina: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.7.6.2. Argentina: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.7.6.3. Argentina: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
8.7.7. Postbiotics Market – Rest of Latin America
8.7.7.1. Rest of Latin America: Postbiotics Market, by Form, 2020-2034 (USD Million)
8.7.7.2. Rest of Latin America: Postbiotics Market, by Type, 2020-2034 (USD Million)
8.7.7.3. Rest of Latin America: Postbiotics Market, by Distribution Channel, 2020-2034 (USD Million)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. Archer-Daniels-Midland Company
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Form Benchmarking
10.1.4. Recent Development
10.2. BASF SE
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Form Benchmarking
10.2.4. Recent Development
10.3. Beekeeper's Naturals, Inc.
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Form Benchmarking
10.3.4. Recent Development
10.4. Bioflag Group
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Form Benchmarking
10.4.4. Recent Development
10.5. Cargill, Incorporated
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Form Benchmarking
10.5.4. Recent Development
10.6. DSM-Firmenich AG
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Form Benchmarking
10.6.4. Recent Development
10.7. Essential Formulas Incorporated
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Form Benchmarking
10.7.4. Recent Development
10.8. Glac Biotech Co., Ltd.
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Form Benchmarking
10.8.4. Recent Development
10.9. Ildong Pharmaceutical Co., Ltd.
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Form Benchmarking
10.9.4. Recent Development
10.10. Kerry Group plc
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Form Benchmarking
10.10.4. Recent Development
10.11. Kemin Industries, Inc.
10.11.1. Company Overview
10.11.2. Financial Performance
10.11.3. Form Benchmarking
10.11.4. Recent Development
10.12. MCLS Europe B.V.
10.12.1. Company Overview
10.12.2. Financial Performance
10.12.3. Form Benchmarking
10.12.4. Recent Development
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.